Crossmark

The oncoprotein TBX3 is controlling severity in experimental arthritis

Crossref DOI link: https://doi.org/10.1186/s13075-018-1797-3

Published Online: 2019-01-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sardar, Samra

Kerr, Alish

Vaartjes, Daniëlle

Moltved, Emilie Riis

Karosiene, Edita

Gupta, Ramneek

Andersson, Åsa https://orcid.org/0000-0003-4360-7710
License Information

Text and Data Mining valid from 2019-01-10
More Information

Article History

Received: 24 July 2018

Accepted: 14 December 2018

First Online: 10 January 2019

Ethics approval

: All animal experiments included in this study were approved by local ethical authorities (Danish Animal Experiment Inspectorate license number: 2010/561–1920 and 2015-15-0201-00794) and were performed in accordance with standard guidelines on the three Rs; replacement, reduction, and refinement.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.